Showing 12,381 - 12,400 results of 38,163 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 12381

    NADPH oxidation and H<sub>2</sub>O<sub>2</sub> production by Bs3 and Bs3<sub>S211A</sub>. by Christina Krönauer (11301989)

    Published 2021
    “…<p>A) Buffer containing 100 μM NADPH was mixed with 0.2 μM Bs3 or Bs3<sub>S211A</sub> and incubated at 25°C. …”
  2. 12382

    BMD analysis of serum free T4 (A), serum free T3 (B) and serum TSH (C) in males (triangles) and females (circles). by Matti Viluksela (321291)

    Published 2014
    “…Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease or increase (CES -0.05) compared to background (a parameter). …”
  3. 12383

    BMD analysis of red cell count (A), hematocrit (B) and hemoglobin (C) in males (triangles) and females (circles). by Matti Viluksela (321291)

    Published 2014
    “…<p>These parameters were dose-dependently decreased in both genders. Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease (CES -0.05) compared to background (a parameter). …”
  4. 12384

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  5. 12385

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  6. 12386

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  7. 12387

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  8. 12388

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  9. 12389

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  10. 12390

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  11. 12391

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  12. 12392

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  13. 12393

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  14. 12394

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  15. 12395

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  16. 12396
  17. 12397
  18. 12398
  19. 12399
  20. 12400